Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. SILO Pharma Inc. (SILO) Message Board

Gun Violence Survivors at Higher Risk of Being Dia

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 138
(Total Views: 177)
Posted On: 04/08/2022 6:00:26 PM
Avatar
Posted By: NetworkNewsWire
Gun Violence Survivors at Higher Risk of Being Diagnosed with Mental Health Issues

Estimates show that in the United States approximately 85,000 individuals survive gun injuries, while another 40,000 are killed by guns annually. New research has found that the consequences of gun violence extend far beyond the damage caused by the injury. Long-term repercussions include substance-use disorders, worsened mental health and increase in healthcare costs incurred for survivors as well as increased mental health conditions for their significant others and children.

The study was carried out by researchers at Harvard Medical School. Its findings were reported in the “Annals of Internal Medicine.” This is the first quasiexperimental, large-scale study to look into the financial and health impact of gun violence over a 12-month period. It is also one of the first studies to quantify how families of gunshot survivors are impacted in regard to their health.

For their study, the researchers analysed decade-old patient records. They discovered that individuals who survived gunshot injuries had a heightened risk of developing substance-use disorders, mental health disorders and pain in the year after the injury. They also found that those who survived firearm injuries paid about $2,490 more in health care every month in comparison with their clinically and demographically matched peers. This discovery suggests that direct health-care costs on account of those injuries equal more than $2 billion in the first year alone.

In addition, the researchers found that gunshot survivors’ immediate family members also suffered tangible but indirect harms, with parents, children and significant others of the survivors showing an increased risk of mental health conditions, including PTSD, anxiety and depression.

Associate Professor Zirui Song of health-care policy at the Harvard Medical School stated that their research had shown that there were significant mental-health consequences for survivors as well as their family members following a shooting, in addition to the obvious physical repercussions of firearm wounds. Song, who is also a physician at Massachusetts General Hospital, explained that understanding how gunshot injuries resounded across the lives of survivors and their families offered insights that could be used to provide patients with better care.

In their report, the researchers recommended that physicians be mindful of a heightened risk of substance-use disorders when treating pain caused by a firearm injury; they also noted that doctors should screen gunshot survivors as well as their family members for signs of mental health conditions. Song also added that it was important that preventative measures be taken to improve the safety of gunshot survivors.

This study confirms that there is a huge pool of gunshot survivors plus their familes that could be in dire need of mental-health treatment. With companies such as Silo Pharma Inc. (OTCQB: SILO) working to develop superior mental-health medicines from psychedelics, the future of these patients could soon be brighter.

NOTE TO INVESTORS: The latest news and updates relating to Silo Pharma Inc. (OTCQB: SILO) are available in the company’s newsroom at https://ibn.fm/SILO

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer





(0)
(0)




SILO Pharma Inc. (SILO) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us